Progyny Balance Sheet
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Progyny financial position
At the end of fiscal 2025, Progyny reported total assets of $742.4 million, up 22.3% from a year earlier against total liabilities of $226.4 million. Shareholders' equity stood at $516.0 million, or 69.5% of assets. The company held $112.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.73, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Progyny balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 112.24M | 162.31M | 97.30M | 120.08M | 91.41M | 70.31M | 80.38M | 127.00K | — |
| Short-Term Investments | 197.86M | 65.64M | 273.79M | 69.22M | 28.00M | 38.99M | — | — | — |
| Receivables | 220.29M | 235.32M | 241.87M | 240.07M | 134.56M | 75.66M | 47.06M | 23.32M | — |
| Total Current Assets | 551.77M | 472.72M | 640.41M | 433.86M | 258.54M | 190.22M | 132.44M | 24.54M | — |
| Property, Plant & Equipment | 29.93M | 12.38M | 10.21M | 8.37M | 5.03M | 3.40M | 3.08M | 776.00K | — |
| Goodwill | 19.98M | 15.53M | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | — |
| Intangible Assets | 6.22M | 1.30M | 0 | 99.00K | 599.00K | 1.21M | 2.38M | 3.86M | — |
| Total Assets | 742.43M | 607.10M | 756.62M | 542.99M | 358.06M | 253.93M | 150.43M | 41.32M | — |
| Accounts Payable | 124.07M | 95.10M | 125.43M | 109.29M | 61.40M | 43.51M | 19.39M | 15.58M | — |
| Short-Term Debt | — | — | — | — | — | — | — | 253.00K | — |
| Total Current Liabilities | 202.39M | 168.63M | 185.95M | 159.54M | 98.82M | 77.79M | 36.16M | 30.20M | — |
| Total Liabilities | 226.39M | 185.04M | 203.19M | 166.02M | 106.24M | 86.98M | 36.16M | 30.20M | — |
| Shareholders' Equity | 516.04M | 422.06M | 553.43M | 376.97M | 251.82M | 166.95M | 114.27M | -95.11M | -97.62M |
| Retained Earnings | 202.83M | 144.31M | 89.97M | 27.93M | -2.42M | -68.19M | -113.48M | -104.85M | — |
| Total Debt | — | — | — | — | — | — | — | 253.00K | — |
| Net Cash (Debt) | 310.10M | 227.95M | 371.09M | 189.30M | 119.42M | 109.30M | 80.38M | -126.00K | — |
| Shares Outstanding | 83.37M | 85.31M | 96.35M | 93.30M | 91.09M | 87.05M | 84.19M | 5.16M | — |
This table shows 9 annual periods of Progyny's balance sheet, from FY 2025 back to FY 2017, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PGNY's reporting calendar. What is a balance sheet?